Lilly has brought out its Glucagon mobile app in a version for Android devices, nearly three years after it first appeared for iPhones.  

The free app, for carers and healthcare providers, serves as a teaching tool and can help patients prepare for insulin coma treatment with Lilly Glucagon for Injection (rDNA origin) during a severe low blood sugar episode. 

It offers an injection tutorial and emergency instructions, and a kit location log, so kits can be easily located during an emergency, and an expiration date log that sends a reminder when a kit is getting close to its expiration date, so a new kit can be obtained before this date.

Matt Caffrey, senior director of consumer marketing at Lilly Diabetes, said: "Lilly Diabetes is committed to developing personalised solutions to help people with diabetes achieve their treatment goals and improve their outcomes - including the creation of innovative online tools that provide a range of support.

"The new version of the Lilly Glucagon Mobile App leverages the power of Android mobile technology, helping us reach even more caregivers and providing another opportunity to support people living with type 1 diabetes."

The company's other diabetes-focused mobile apps include Lilly AudioTour for poster sessions at last month's American Diabetes Association congress and the Trulicity Reminder app for UK patients taking its once-weekly GLP-1 agonist.

More recently the company took a stake in digital health firm Companion Medical, a San Diego-based company that's working on a Bluetooth-enabled insulin pen and associated smartphone app.

Digital inspiration for pharma on mobile, social media, strategy, best practice, regulations and more